New therapy teplizumab could delay type 1 diabetes by years – if caught early
For more than a century, type 1 diabetes has meant one thing: a lifetime administering insulin. But for the first time, science is breaking that paradigm – not by managing the disease, but by intercepting it before symptoms even appear.
The Conversation ·